BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper Robotic Instrumentation and Molecular Testing
Advertisement
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced the signing of an agreement with BioReference Laboratories of Elmwood Park, NJ (BRLI) for BD to supply BRLI with instrumentation and reagents for testing and diagnosis of sexually transmitted infections (STI).
Under this agreement testing for Chlamydia trachomatis and Neisseria gonorrhoeae will be run on the SCARA robotic automation platform of the BD Viper(TM) System. BD will be the primary supplier to BioReference for testing of these two infectious diseases.
Most read news
Other news from the department business & finance
These products might interest you
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Intercytex - Cambridge, United Kingdom
Puccinia_erianthi
Scil Proteins GmbH - Halle (Saale), Germany
You’re using surfactants like Triton X-100? The REACH clock is ticking … - Download information to see your options, including suggested alternatives to NPEs / OPEs and an application note
Category:Medical_research_institutes
Corallina_officinalis